Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Acute Hepatitis C Virus Infection Treated With Daclatasvir/Sofosbuvir in a 9-Year-Old Boy Publisher



Rahmani P1 ; Farahmand F2 ; Heidari G3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Pediatric Gastroenterology and Hepatology Research Center, Pediatric Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pediatric Gastroenterology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Pediatric, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran

Source: Journal of Child Science Published:2022


Abstract

The present study includes a case report of a 9-year-old boy who came to our center with jaundice, elevated liver enzymes, and palpable liver. He was treated with ursodeoxycholic acid, but no improvement in symptoms was seen. Reverse transcription polymerase chain reaction and liver biopsy were positive for hepatitis C virus. He was treated with daclatasvir/sofosbuvir for 3 months. Daclatasvir/sofosbuvir might be effective against the treatment of hepatitis in children, with no report of remission and minimal side effects. © 2022. The Author(s).